Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study

By afschroeder • August 30, 2025

Armstrong AW, Mburu S, Gondo GC, Kornyeyeva E, Frade S, Ogdie A. Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study. Drugs Real World Outcomes. 2025 Aug 29. doi: 10.1007/s40801-025-00499-6. Epub ahead of print. PMID: 40879928.

Tags: Dermatology, Publications

Safety and Efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the Phase 2 STRIDE study

Papp KA, Jacobs S, Sofen H, Bukhalo M, Muscianisi E, Ma G, Lau G, Bettinger M, Rubio RG, Hitraya E, Blauvelt A; Open-Label Extension study[...]

Differentially Expressed Salivary miRNAs in Temporomandibular Disorders

Kaczor-Urbanowicz KE, Aziz M, Wilhalme H, Aronovich S, Hatfield ER, Aghaloo T, Arman S, Mohammadi A, Husain M, Tetradis S, Elashoff D, Pellegrini M, Wong[...]

Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman

Saka F, McKenzie S, Milani-Nejad N, Smart C. Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm Presenting on the Breast of a 44-Year-Old Woman. Am J[...]